EP 0521009 A1 19930107 - USE OF 5-TRANS PROSTAGLANDIN F 2-g(a)? AS AN OCULAR HYPOTENSIVE AGENT.
Title (en)
USE OF 5-TRANS PROSTAGLANDIN F 2-g(a)? AS AN OCULAR HYPOTENSIVE AGENT.
Title (de)
VERWENDUNG VON 5-TRANS-PROSTAGLANDIN-2-ALPHA ALS EIN HYPOTENSIVER WIRKSTOFF AM AUGE.
Title (fr)
UTILISATION DE 5-TRANS PROSTAGLANDINE F 2-g(a)? COMME AGENT HYPOTENSIF OCULAIRE.
Publication
Application
Priority
US 49687990 A 19900319
Abstract (en)
[origin: WO9114428A1] The invention relates to a means of reducing or maintaining intraocular pressure, and, more particularly, to a method and composition for reducing or maintaining intraocular pressure involving the administration of a composition containing 5-trans prostaglandin F2 alpha in a pharmaceutically acceptable carrier.
Abstract (fr)
Cette invention concerne un moyen de réduire ou de maintenir la pression intraoculaire, et, plus particulièremenet, une méthode et une composition pour réduire ou maintenir la pression intraoculaire consistant à administrer une composition contenant du 5-trans prostaglandine F2alpha dans un support pharmaceutiquement acceptable.
IPC 1-7
IPC 8 full level
A61K 31/557 (2006.01); A61P 9/12 (2006.01); A61P 27/02 (2006.01)
CPC (source: EP)
A61K 31/557 (2013.01); A61P 9/12 (2017.12); A61P 27/02 (2017.12)
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9114428 A1 19911003; CA 2076023 A1 19910920; EP 0521009 A1 19930107; EP 0521009 A4 19930224; FI 924205 A0 19920918; FI 924205 A 19920918; HU 9202572 D0 19921228; HU T61666 A 19930301; IE 910865 A1 19910925; JP H05505605 A 19930819
DOCDB simple family (application)
US 9100986 W 19910212; CA 2076023 A 19910212; EP 91905501 A 19910212; FI 924205 A 19920918; HU 257292 A 19910212; IE 86591 A 19910315; JP 50535691 A 19910212